These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8174823)

  • 21. Considerations and potential pitfalls in AIDS lab testing.
    Wecht CH
    J Leg Med; 1988 Dec; 9(4):623-35. PubMed ID: 3244009
    [No Abstract]   [Full Text] [Related]  

  • 22. Serologic markers of neurologic diseases: the control groups.
    Cohen AB
    Ann Neurol; 2010 Mar; 67(3):409; author reply 409. PubMed ID: 20373356
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening of blood donors for antibody to human immunodeficiency virus type 1.
    Acquaye JK
    West Afr J Med; 1993; 12(2):93-5. PubMed ID: 8398939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors.
    Busch MP
    Transfusion; 2006 Oct; 46(10):1663-6. PubMed ID: 17002621
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening for HIV seropositive blood - a critical evaluation.
    Verma A; Pandey J; Khurana SK; Garg M; Talib VH
    Indian J Pathol Microbiol; 1995 Apr; 38(2):163-8. PubMed ID: 8919102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety.
    Zou S; Fujii K; Johnson S; Spencer B; Washington N; Iv EN; Musavi F; Newman B; Cable R; Rios J; Hillyer KL; Hillyer CD; Dodd RY;
    Transfusion; 2006 Nov; 46(11):1997-2003. PubMed ID: 17076856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of serological reactions in infectious diseases].
    Sommergruber D; Blatz R; Falkenhagen U; Lange R; Müller WA
    Z Arztl Fortbild (Jena); 1982 Mar; 76(6):234-9. PubMed ID: 7051587
    [No Abstract]   [Full Text] [Related]  

  • 28. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid testing in jails.
    AIDS Patient Care STDS; 2004 May; 18(5):321. PubMed ID: 15209065
    [No Abstract]   [Full Text] [Related]  

  • 30. [Viral serology in haemodialysis outpatients. What is reasonable to request?].
    Arenas MD
    Nefrologia; 2009; 29(1):89-90. PubMed ID: 19240784
    [No Abstract]   [Full Text] [Related]  

  • 31. [Characteristics of serologic blood tests in Croatia].
    Mihaljević I
    Lijec Vjesn; 2007 May; 129 Suppl 3():22-6. PubMed ID: 18959055
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of prevalence rates of microbiological markers between bone/tissue donations and new blood donors in Scotland.
    Galea G; Dow BC
    Vox Sang; 2006 Jul; 91(1):28-33. PubMed ID: 16756598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of increased neopterin levels in reducing transfusion-transmitted virus infections: detection of a donation from a HBsAg positive chronic carrier by screening of neopterin in Turkish blood donors.
    Inci Fisenk B; Us D; Ozcebe OI; Hascelik G
    Scand J Infect Dis; 2005; 37(8):599-604. PubMed ID: 16099770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia.
    Sabery N; Bass D
    Pediatrics; 2007 Jan; 119(1):e193-9. PubMed ID: 17158948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Application of screening methods in virological serology (author's transl)].
    Bruj J
    Cesk Epidemiol Mikrobiol Imunol; 1980 Mar; 29(2):88-92. PubMed ID: 6446980
    [No Abstract]   [Full Text] [Related]  

  • 36. First fully automated blood screening test for HCV antibodies approved.
    AIDS Patient Care STDS; 2007 Aug; 21(8):608. PubMed ID: 17902247
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of a major earthquake on blood donor types and infectious diseases marker rates.
    Sönmezoglu M; Kocak N; Oncul O; Ozbayburtlu S; Hepgul Z; Kosan E; Aksu Y; Bayik M
    Transfus Med; 2005 Apr; 15(2):93-7. PubMed ID: 15859974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Determine HIV-1/2 rapid diagnostic test by 4th generation ELISA using blood donors' serum at Felege Hiwot Referral Hospital, northwest Ethiopia.
    Dessie A; Abera B; Walle F; Wolday D; Tamene W
    Ethiop Med J; 2008 Jan; 46(1):1-5. PubMed ID: 18714458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on laboratory productivity with infectious disease assays on the Bayer ADVIA Centaur Immunoassay System.
    Dati F
    Clin Lab; 2004; 50(1-2):53-61. PubMed ID: 15000221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microtiter and automated serologic techniques for diagnostic virology.
    Carbrey EA; Downing DR; Snyder ML; Wessman SJ; Gustafson GA
    Proc Annu Meet U S Anim Health Assoc; 1973; (77):553-62. PubMed ID: 4534734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.